Difference between revisions of "Team:Amsterdam"
Line 12: | Line 12: | ||
multiple bacterial species, can be used for higher yields, robustness and more | multiple bacterial species, can be used for higher yields, robustness and more | ||
diverse purposes. Our goal is to tap into this potential by creating a self-sustaining | diverse purposes. Our goal is to tap into this potential by creating a self-sustaining | ||
− | bio-factory of cyanobacteria - little fellows that need only | + | bio-factory of cyanobacteria - little fellows that need only CO<sub>2</sub> and light - and product-producing E. coli, the general workhorse of the synthetic biology world.</p> |
<p align="justify"> | <p align="justify"> | ||
− | In short: the cyanobacteria will create sugars from | + | In short: the cyanobacteria will create sugars from CO<sub>2</sub> and sunlight, which it will |
release and feed to E. coli as a result of our applied synthetic genetic circuits. E. | release and feed to E. coli as a result of our applied synthetic genetic circuits. E. | ||
coli will then be engineered to use these sugars to create a product. In our | coli will then be engineered to use these sugars to create a product. In our | ||
Line 21: | Line 21: | ||
be expanded to produce any product E. coli can fabricate - medicine, plastics, | be expanded to produce any product E. coli can fabricate - medicine, plastics, | ||
commodity chemicals - as long as it is fueled by the cyanobacteria that only needs | commodity chemicals - as long as it is fueled by the cyanobacteria that only needs | ||
− | light and | + | light and CO<sub>2</sub>.</p> |
Revision as of 11:04, 14 May 2015
Sorry, this page is under construction!
Very recently, there’s been a small shift in the world of synthetic biology. Rather than focus on single organisms - the modus operandi of the biotech industry - researchers are starting to recognize that synthetic ecosystems, consortia of multiple bacterial species, can be used for higher yields, robustness and more diverse purposes. Our goal is to tap into this potential by creating a self-sustaining bio-factory of cyanobacteria - little fellows that need only CO2 and light - and product-producing E. coli, the general workhorse of the synthetic biology world.
In short: the cyanobacteria will create sugars from CO2 and sunlight, which it will release and feed to E. coli as a result of our applied synthetic genetic circuits. E. coli will then be engineered to use these sugars to create a product. In our proof-of-concept bio-factory, this product will be fuel. This platform, however, can be expanded to produce any product E. coli can fabricate - medicine, plastics, commodity chemicals - as long as it is fueled by the cyanobacteria that only needs light and CO2.